Asset Detail
Anmelden
Hallo
OpenSPY BTC ETH NDX
ARB

ARB

crypto71Highbuy

Arbitrum

$1.142
+5.12% today

Price

Key Metrics

Volume (24h)
$384M
Market cap
$2.21T
52w high
$1.35
52w low
$0.71
Realized vol
34.2%
Beta vs SPY
1.42
Liquidity score
92/100
AI quality
67/100

AI News Summary

Updated 2m ago

Earnings reaction: ARB traded above consensus on accelerated revenue growth. Forward guidance lifted, with management citing structural demand from enterprise AI buildouts.

Flow & positioning: Options skew tilted toward calls in front-month expiries; gamma exposure remains positive. Institutional order flow net buyers over the trailing 5 sessions.

Risks called out: Concentration in single end-market, regulatory overhang in semis trade restrictions, valuation now in the 90th percentile of the 5-year range.

Risk Breakdown

Volatility72
Liquidity88
News intensity64
Correlation cluster41
Drawdown sensitivity58

Scenario Analysis

Bear
$0.94
-18% · 12w horizon
Base
$1.18
+3% · 12w horizon
Bull
$1.38
+21% · 12w horizon

Trade Setup Summary

BiasLong bias
Entry zone$1.13 – $1.15
Stop-loss$1.10 (-4.0%)
Take-profit$1.23 (+8.0%)
Risk / reward1 : 2.0
Suggested position1.0% portfolio

AI Sentiment

KI-Analyse der letzten News

KI analysiert News…

AI Recommendation

Why the model is leaning this way

  1. 1Trend regime classifier reports a confirmed up-trend on the daily timeframe with 14-day ADX rising.
  2. 2News sentiment net positive over rolling 72h window; no material negative catalysts identified.
  3. 3Volatility surface flattening relative to 30-day average — supportive of directional positioning.
  4. 4Risk score sits below portfolio-wide threshold; suggested sizing respects max concentration rule.

What this means

Plain-language read of the current situation

ARB looks technically constructive with supportive flows and sentiment, but the move comes with elevated volatility. If you participate, the model would prefer a measured position size with a defined stop. This is not a recommendation — it's an analytical read. Always cross-check against your own thesis and risk limits.